Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lineage Cell Therapeutics, Inc.

LCTX Clue Score43
United States Fiscal year ends December CIK 0000876343 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Brian M Culley
30 Jun 2021
President and CEO
Exercised, kept
15,450
$2.85
$44.03K
Neal C Bradsher
25 Jun 2021
Director
Exercised, kept
24,720
$2.20
$54.38K
Alfred D Kingsley
22 Jun 2021
Director
Exercised, kept
61,800
$2.20
$135.96K
Michael H. Mulroy
18 Jun 2021
Director
Exercised, kept
24,720
$2.20
$54.38K
Brian M Culley
31 Mar 2021
President and CEO
Exercised, kept
15,450
$2.35
$36.31K
Brian M Culley
31 Dec 2020
President and CEO
Exercised, kept
15,450
$1.76
$27.19K
Brian M Culley
30 Sep 2020
President and CEO
Exercised, kept
15,450
$0.94
$14.47K
Brian M Culley
30 Jun 2020
President and CEO
Exercised, kept
15,450
$0.87
$13.44K
Brian M Culley
31 Mar 2020
President and CEO
Exercised, kept
15,450
$0.83
$12.79K

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 1
Filings about a different issuer 3
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 6,870,572
Sales filed before the plan box existed 1
History held since 28 Nov 2006